Hofs S, Mogavero S, Hube B
J Microbiol. 2016; 54(3):149-69.
PMID: 26920876
DOI: 10.1007/s12275-016-5514-0.
Bahrami F, Kukulski F, Lecka J, Tremblay A, Pelletier J, Rockenbach L
Mediators Inflamm. 2014; 2014:879895.
PMID: 25242873
PMC: 4158428.
DOI: 10.1155/2014/879895.
Weng M, Walker W
J Dev Orig Health Dis. 2013; 4(3):203-14.
PMID: 24353893
PMC: 3864895.
DOI: 10.1017/S2040174412000712.
Shi G, Vistica B, Nugent L, Tan C, Wawrousek E, Klinman D
J Immunol. 2013; 191(1):415-23.
PMID: 23720812
PMC: 3749791.
DOI: 10.4049/jimmunol.1201732.
Teng G, Wang W, Dai Y, Wang S, Chu Y, Li J
PLoS One. 2013; 8(2):e56709.
PMID: 23437218
PMC: 3577724.
DOI: 10.1371/journal.pone.0056709.
The skin microbiome.
Grice E, Segre J
Nat Rev Microbiol. 2011; 9(4):244-53.
PMID: 21407241
PMC: 3535073.
DOI: 10.1038/nrmicro2537.
Epithelial cells and innate antifungal defense.
Weindl G, Wagener J, Schaller M
J Dent Res. 2010; 89(7):666-75.
PMID: 20395411
PMC: 3318078.
DOI: 10.1177/0022034510368784.
Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7.
Calderon Toledo C, Rogers T, Svensson M, Tati R, Fischer H, Svanborg C
Am J Pathol. 2008; 173(5):1428-39.
PMID: 18832584
PMC: 2570133.
DOI: 10.2353/ajpath.2008.071218.
Innate immunity and intestinal microbiota in the development of Type 1 diabetes.
Wen L, Ley R, Volchkov P, Stranges P, Avanesyan L, Stonebraker A
Nature. 2008; 455(7216):1109-13.
PMID: 18806780
PMC: 2574766.
DOI: 10.1038/nature07336.
Role of MyD88 in TLR agonist-induced functional alterations of human adipose tissue-derived mesenchymal stem cells.
Yu S, Cho H, Joo H, Bae Y, Jung J
Mol Cell Biochem. 2008; 317(1-2):143-50.
PMID: 18581201
DOI: 10.1007/s11010-008-9842-1.
Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling.
Weindl G, Naglik J, Kaesler S, Biedermann T, Hube B, Korting H
J Clin Invest. 2007; 117(12):3664-72.
PMID: 17992260
PMC: 2066194.
DOI: 10.1172/JCI28115.
A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection.
Chen X, Splinter P, OHara S, LaRusso N
J Biol Chem. 2007; 282(39):28929-28938.
PMID: 17660297
PMC: 2194650.
DOI: 10.1074/jbc.M702633200.
Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin.
Sugita K, Kabashima K, Atarashi K, Shimauchi T, Kobayashi M, Tokura Y
Clin Exp Immunol. 2006; 147(1):176-83.
PMID: 17177977
PMC: 1810440.
DOI: 10.1111/j.1365-2249.2006.03258.x.
Flagellin suppresses epithelial apoptosis and limits disease during enteric infection.
Vijay-Kumar M, Wu H, Jones R, Grant G, Babbin B, King T
Am J Pathol. 2006; 169(5):1686-700.
PMID: 17071592
PMC: 1780197.
DOI: 10.2353/ajpath.2006.060345.
Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.
Foligne B, Nutten S, Steidler L, Dennin V, Goudercourt D, Mercenier A
Dig Dis Sci. 2006; 51(2):390-400.
PMID: 16534687
DOI: 10.1007/s10620-006-3143-x.
Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation.
Rhee S, Im E, Riegler M, Kokkotou E, OBrien M, Pothoulakis C
Proc Natl Acad Sci U S A. 2005; 102(38):13610-5.
PMID: 16157881
PMC: 1224619.
DOI: 10.1073/pnas.0502174102.
Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
Pedersen G, Andresen L, Matthiessen M, Rask-Madsen J, Brynskov J
Clin Exp Immunol. 2005; 141(2):298-306.
PMID: 15996194
PMC: 1809430.
DOI: 10.1111/j.1365-2249.2005.02848.x.
